Halfdan Sørbye
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis 23
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies 60
- Lung Cancer Research Studies 54
- Pancreatic and Hepatic Oncology Research 28
- Neurology top 0.5%
- Neuroblastoma Research and Treatments 32
- Epidemiology top 0.5%
- Neuroendocrine Tumor Research Advances 58
-
- Gastric Cancer Management and Outcomes 21
-
- Genetic factors in colorectal cancer 25
Halfdan Sørbye
155 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Hepatology 2.2k
- Oncology 6.5k
- Neurology 2.1k
- Epidemiology 3.4k
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Halfdan Sørbye
This map shows the geographic impact of Halfdan Sørbye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halfdan Sørbye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halfdan Sørbye more than expected).
Fields of papers citing papers by Halfdan Sørbye
This network shows the impact of papers produced by Halfdan Sørbye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halfdan Sørbye. The network helps show where Halfdan Sørbye may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Halfdan Sørbye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 8 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 32 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 2 | |
| 13 | 2020 | 18 | |
| 14 | 2018 | 10 | |
| 15 | 2018 | 65 | |
| 16 | 2017 | 82 | |
| 17 | 2017 | 110 | |
| 18 | 2017 | 27 | |
| 19 | ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomasbreakdown → | 2016 | 403 |
| 20 | Helseøkonomisk evaluering av bevacizumab ved metastatisk kolorektalcancer | 2007 | 2 |
About Halfdan Sørbye
Halfdan Sørbye is a scholar working on Oncology, Hepatology, Neurology, Epidemiology and Pathology and Forensic Medicine, having authored 160 papers that have together received 8.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (60 papers), Neuroendocrine Tumor Research Advances (58 papers), Lung Cancer Research Studies (54 papers), Neuroblastoma Research and Treatments (32 papers), Pancreatic and Hepatic Oncology Research (28 papers), Genetic factors in colorectal cancer (25 papers), Hepatocellular Carcinoma Treatment and Prognosis (23 papers) and Gastric Cancer Management and Outcomes (21 papers). The work is most often cited by research in Hepatology (2.2k citations), Oncology (6.5k citations), Neurology (2.1k citations), Epidemiology (3.4k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Halfdan Sørbye has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Bengt Glimelius, Bernard Nordlinger, Thomas Gruenberger, Wolf O. Bechstein, John Primrose, Peter M. Schlag, Graeme J. Poston, Euan Walpole, Rowan W. Parks and Werner Scheithauer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Acta Oncologica, Neuroendocrinology and Journal of Neuroendocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.